Skip to main content

A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of dupilumab in children 6 to <12 years of age with uncontrolled persistent asthma STUDY NUMBER: EFC14153

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Pulmonary and Sleep Medicine

Awarded By

Sanofi US

Start Date

October 25, 2017

End Date

September 30, 2019
 

Administered By

Pediatrics, Pulmonary and Sleep Medicine

Awarded By

Sanofi US

Start Date

October 25, 2017

End Date

September 30, 2019